Dapagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitors used in the treatment of patients with type 2 diabetes. An aryl glycoside significant effect as glucose-lowering agents, also has indication for Heart Failure and Chronic Kidney Disease. This review examines structure, synthesis, analysis, structure activity relationship uses product. The studies behind this drug have opened ...
